{
  "pmid": "26233723",
  "uid": "26233723",
  "title": "Policies, Guidelines and Consensus Statements: Pharmacologic Management of Type 2 Diabetes-2015 Interim Update.",
  "abstract": "",
  "authors": [
    {
      "affiliations": []
    },
    {
      "last_name": "Harper",
      "fore_name": "William",
      "initials": "W",
      "name": "William Harper",
      "affiliations": []
    },
    {
      "last_name": "Clement",
      "fore_name": "Maureen",
      "initials": "M",
      "name": "Maureen Clement",
      "affiliations": []
    },
    {
      "last_name": "Goldenberg",
      "fore_name": "Ronald",
      "initials": "R",
      "name": "Ronald Goldenberg",
      "affiliations": []
    },
    {
      "last_name": "Hanna",
      "fore_name": "Amir",
      "initials": "A",
      "name": "Amir Hanna",
      "affiliations": []
    },
    {
      "last_name": "Main",
      "fore_name": "Andrea",
      "initials": "A",
      "name": "Andrea Main",
      "affiliations": []
    },
    {
      "last_name": "Retnakaran",
      "fore_name": "Ravi",
      "initials": "R",
      "name": "Ravi Retnakaran",
      "affiliations": []
    },
    {
      "last_name": "Sherifali",
      "fore_name": "Diana",
      "initials": "D",
      "name": "Diana Sherifali",
      "affiliations": []
    },
    {
      "last_name": "Woo",
      "fore_name": "Vincent",
      "initials": "V",
      "name": "Vincent Woo",
      "affiliations": []
    },
    {
      "last_name": "Yale",
      "fore_name": "Jean-François",
      "initials": "JF",
      "name": "Jean-François Yale",
      "affiliations": []
    },
    {
      "last_name": "Cheng",
      "fore_name": "Alice Y Y",
      "initials": "AY",
      "name": "Alice Y Y Cheng",
      "affiliations": []
    },
    {
      "affiliations": []
    }
  ],
  "journal": {
    "title": "Canadian journal of diabetes",
    "iso_abbreviation": "Can J Diabetes",
    "issn": "2352-3840",
    "issn_type": "Electronic",
    "volume": "39",
    "issue": "4",
    "pub_year": "2015",
    "pub_month": "Aug"
  },
  "start_page": "250",
  "end_page": "252",
  "pages": "250-2",
  "language": "eng",
  "publication_types": [
    "Journal Article",
    "Review"
  ],
  "keywords": [
    "Canada",
    "Canagliflozin",
    "Consensus",
    "Diabetes Mellitus, Type 2",
    "Disease Management",
    "Health Policy",
    "Humans",
    "Hypoglycemic Agents",
    "Practice Guidelines as Topic",
    "Sodium-Glucose Transporter 2",
    "Sodium-Glucose Transporter 2 Inhibitors"
  ],
  "article_ids": {
    "pubmed": "26233723",
    "doi": "10.1016/j.jcjd.2015.05.009",
    "pii": "S1499-2671(15)00474-8"
  },
  "doi": "10.1016/j.jcjd.2015.05.009",
  "dates": {
    "completed": "2016-05-20",
    "revised": "2019-12-10"
  },
  "chemicals": [
    "Hypoglycemic Agents",
    "SLC5A2 protein, human",
    "Sodium-Glucose Transporter 2",
    "Sodium-Glucose Transporter 2 Inhibitors",
    "Canagliflozin"
  ],
  "grants": [],
  "search_metadata": {
    "search_type": "all_publications",
    "retrieved_date": "2025-07-30T14:58:28.922176",
    "pmid": "26233723"
  }
}